Christos Gavriel
About Christos Gavriel
Christos Gavriel is a scientist specializing in discovery research, currently employed at Adaptimmune since 2022. He has a strong academic background in biology and cancer sciences, holding a PhD from the University of St Andrews and a Master's degree from the University of Glasgow.
Current Role at Adaptimmune
Christos Gavriel currently serves as a Scientist in Discovery Research at Adaptimmune, a position he has held since 2022. In this role, he focuses on advancing research initiatives aimed at developing innovative therapies in the field of immuno-oncology. His contributions are integral to the company's mission of harnessing the power of the immune system to treat cancer.
Previous Experience at GammaDelta Therapeutics
Prior to his current role, Christos Gavriel worked at GammaDelta Therapeutics as an Associate Scientist for 11 months in 2021. His responsibilities included conducting research and experiments that contributed to the understanding of gamma delta T cells and their potential applications in cancer treatment.
Educational Background in Cancer Sciences
Christos Gavriel completed his Master of Science in Cancer Sciences at The University of Glasgow from 2015 to 2016. This program provided him with a solid foundation in cancer biology and therapeutic strategies, which he has applied throughout his career in research.
PhD Studies at University of St Andrews
Christos Gavriel pursued his Doctor of Philosophy at the University of St Andrews from 2016 to 2020. During this four-year program, he focused on research within the School of Medicine, contributing to the academic community through his studies and findings related to medical science.
Undergraduate Education in Biology
Christos Gavriel earned his Bachelor's degree in Biology from the National & Kapodistrian University of Athens. This foundational education equipped him with essential knowledge in biological sciences, which has been pivotal in his subsequent academic and professional pursuits.